扶桑薬品工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/02/27 | 1,996 | 1,996 | 1,981 | 1,996 | +19 | +1% | 4,000 |
| 2023/02/24 | 1,958 | 1,979 | 1,958 | 1,977 | +12 | +0.6% | 3,000 |
| 2023/02/22 | 1,967 | 1,971 | 1,955 | 1,965 | -6 | -0.3% | 2,600 |
| 2023/02/21 | 1,952 | 1,976 | 1,952 | 1,971 | +17 | +0.9% | 2,700 |
| 2023/02/20 | 1,970 | 1,985 | 1,954 | 1,954 | -16 | -0.8% | 9,200 |
| 2023/02/17 | 1,968 | 1,974 | 1,951 | 1,970 | +1 | +0.1% | 3,000 |
| 2023/02/16 | 1,951 | 1,969 | 1,945 | 1,969 | +22 | +1.1% | 4,600 |
| 2023/02/15 | 1,982 | 1,982 | 1,947 | 1,947 | -18 | -0.9% | 3,100 |
| 2023/02/14 | 1,958 | 1,970 | 1,952 | 1,965 | +17 | +0.9% | 4,200 |
| 2023/02/13 | 1,963 | 1,963 | 1,936 | 1,948 | -18 | -0.9% | 2,700 |
| 2023/02/10 | 1,915 | 1,988 | 1,915 | 1,966 | +36 | +1.9% | 10,800 |
| 2023/02/09 | 1,921 | 1,930 | 1,921 | 1,930 | +3 | +0.2% | 600 |
| 2023/02/08 | 1,921 | 1,931 | 1,921 | 1,927 | ±0 | ±0% | 1,000 |
| 2023/02/07 | 1,924 | 1,940 | 1,924 | 1,927 | -10 | -0.5% | 1,200 |
| 2023/02/06 | 1,960 | 1,960 | 1,935 | 1,937 | +17 | +0.9% | 4,700 |
| 2023/02/03 | 1,923 | 1,928 | 1,913 | 1,920 | -16 | -0.8% | 2,900 |
| 2023/02/02 | 1,954 | 1,954 | 1,935 | 1,936 | -14 | -0.7% | 6,100 |
| 2023/02/01 | 1,954 | 1,955 | 1,943 | 1,950 | +15 | +0.8% | 2,000 |
| 2023/01/31 | 1,915 | 1,952 | 1,915 | 1,935 | +47 | +2.5% | 11,300 |
| 2023/01/30 | 1,943 | 1,964 | 1,888 | 1,888 | -70 | -3.6% | 15,700 |
| 2023/01/27 | 1,956 | 1,958 | 1,933 | 1,958 | +8 | +0.4% | 6,800 |
| 2023/01/26 | 1,952 | 1,956 | 1,937 | 1,950 | -10 | -0.5% | 4,200 |
| 2023/01/25 | 1,947 | 1,960 | 1,941 | 1,960 | +10 | +0.5% | 3,900 |
| 2023/01/24 | 1,948 | 1,950 | 1,936 | 1,950 | +10 | +0.5% | 4,500 |
| 2023/01/23 | 1,948 | 1,948 | 1,927 | 1,940 | +13 | +0.7% | 4,900 |
| 2023/01/20 | 1,922 | 1,927 | 1,916 | 1,927 | -14 | -0.7% | 6,500 |
| 2023/01/19 | 1,926 | 1,941 | 1,926 | 1,941 | +6 | +0.3% | 4,000 |
| 2023/01/18 | 1,893 | 1,935 | 1,890 | 1,935 | +50 | +2.7% | 8,800 |
| 2023/01/17 | 1,880 | 1,885 | 1,879 | 1,885 | +5 | +0.3% | 3,200 |
| 2023/01/16 | 1,905 | 1,915 | 1,880 | 1,880 | -25 | -1.3% | 9,800 |
| 2023/01/13 | 1,927 | 1,927 | 1,905 | 1,905 | -24 | -1.2% | 6,200 |
| 2023/01/12 | 1,963 | 1,963 | 1,929 | 1,929 | -36 | -1.8% | 5,800 |
| 2023/01/11 | 1,934 | 1,965 | 1,933 | 1,965 | +31 | +1.6% | 5,100 |
| 2023/01/10 | 1,944 | 1,960 | 1,934 | 1,934 | -21 | -1.1% | 3,500 |
| 2023/01/06 | 1,938 | 1,967 | 1,938 | 1,955 | +16 | +0.8% | 4,000 |
| 2023/01/05 | 1,969 | 1,974 | 1,939 | 1,939 | -11 | -0.6% | 3,900 |
| 2023/01/04 | 1,998 | 1,998 | 1,950 | 1,950 | -48 | -2.4% | 4,800 |
| 2022/12/30 | 1,991 | 1,998 | 1,986 | 1,998 | +8 | +0.4% | 4,400 |
| 2022/12/29 | 1,983 | 1,990 | 1,939 | 1,990 | +28 | +1.4% | 7,600 |
| 2022/12/28 | 1,945 | 1,962 | 1,932 | 1,962 | +19 | +1% | 7,400 |
| 2022/12/27 | 1,946 | 1,947 | 1,938 | 1,943 | -3 | -0.2% | 5,300 |
| 2022/12/26 | 1,955 | 1,964 | 1,935 | 1,946 | -7 | -0.4% | 6,600 |
| 2022/12/23 | 1,960 | 1,960 | 1,945 | 1,953 | -18 | -0.9% | 4,500 |
| 2022/12/22 | 1,977 | 1,979 | 1,961 | 1,971 | -2 | -0.1% | 7,700 |
| 2022/12/21 | 1,990 | 2,024 | 1,970 | 1,973 | -25 | -1.3% | 13,200 |
| 2022/12/20 | 2,071 | 2,071 | 1,989 | 1,998 | -23 | -1.1% | 22,900 |
| 2022/12/19 | 1,975 | 2,027 | 1,972 | 2,021 | +46 | +2.3% | 9,700 |
| 2022/12/16 | 2,035 | 2,035 | 1,975 | 1,975 | -60 | -2.9% | 15,100 |
| 2022/12/15 | 2,046 | 2,050 | 2,031 | 2,035 | +1 | ±0% | 7,100 |
| 2022/12/14 | 2,035 | 2,038 | 2,016 | 2,034 | +16 | +0.8% | 7,600 |
301～
350
件表示中 / 3458件
類似銘柄と比較する
現在ご覧いただいている「扶桑薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 扶桑薬 | 228,700円 | +2.9% | +23.1% | 3.50% | 11.50倍 | 0.53倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| セルソース | 141,900円 | +19.0% | -13.1% | 0.35% | 39.09倍 | 4.57倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| クオリプス | 323,000円 | -13.0% | - | 0.00% | - | 4.30倍 |
|
大阪大学発ベンチャー。ｉＰＳ細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
| 大幸薬品 | 40,000円 | +11.1% | - | 0.00% | 36.50倍 | 2.98倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
| オンコリス | 64,900円 | +217.5% | - | 0.00% | - | 9.28倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
市場注目の銘柄
チャート関連のコラム
